ORBIMED ADVISORS LLC Q4 2018 Filing
Filed February 14, 2019
Portfolio Value
$5.4T
Holdings
127
Report Date
Q4 2018
Filing Type
13F-HR
All Holdings (127 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | APLSAPELLIS PHARMACEUTICALS INC | 327,000 | $4.3B | 0.08% | |
| 102 | SELBUSDSELECTA BIOSCIENCES INC | 1,579,064 | $4.2B | 0.08% | |
| 103 | —AVROBIO INC | 249,900 | $4.2B | 0.08% | |
| 104 | —NOVUS THERAPEUTICS INC | 2,537,110 | $4.1B | 0.08% | |
| 105 | XENEXENON PHARMACEUTICALS INC | 634,812 | $4.0B | 0.07% | |
| 106 | CTIC1USDCTI BIOPHARMA CORP | 5,000,000 | $3.7B | 0.07% | |
| 107 | SG7SAGE THERAPEUTICS INC | 36,300 | $3.5B | 0.06% | |
| 108 | —CONSTELLATION PHARMCETICLS I | 835,842 | $3.4B | 0.06% | |
| 109 | AM6AMICUS THERAPEUTICS INC | 323,009 | $3.1B | 0.06% | |
| 110 | —111 INC | 500,000 | $3.1B | 0.06% | |
| 111 | —RA MED SYS INC | 350,000 | $2.8B | 0.05% | |
| 112 | ECORGBPELECTROCORE INC | 397,826 | $2.5B | 0.05% | |
| 113 | —REALM THERAPEUTICS PLC | 1,021,484 | $1.9B | 0.03% | |
| 114 | —AEGERION PHARMACEUTICALS INC | 2,000,000 | $1.7B | 0.03% | |
| 115 | —MARINUS PHARMACEUTICALS INC | 498,101 | $1.4B | 0.03% | |
| 116 | AMRNAMARIN CORP PLC | 81,000 | $1.1B | 0.02% | |
| 117 | —MEDICINES CO | 54,600 | $1.0B | 0.02% | |
| 118 | —AFFIMED N V | 326,650 | $1.0B | 0.02% | |
| 119 | SNDXSYNDAX PHARMACEUTICALS INC | 212,000 | $943.0M | 0.02% | |
| 120 | —ADAMAS PHARMACEUTICALS INC | 100,000 | $854.0M | 0.02% | Call |
| 121 | SCTLRECRO PHARMA INC | 107,357 | $762.0M | 0.01% | |
| 122 | —SIERRA ONCOLOGY INC | 417,104 | $551.0M | 0.01% | |
| 123 | —BIOLINERX LTD | 1,038,600 | $454.0M | 0.01% | |
| 124 | RDHLGBPREDHILL BIOPHARMA LTD | 54,600 | $303.0M | 0.01% | |
| 125 | —ALIMERA SCIENCES INC | 250,000 | $180.0M | 0.00% | |
| 126 | —WRIGHT MED GROUP N V | 8,746,583 | $109.0M | 0.00% | |
| 127 | —MEDIGUS LTD | 15,000 | $39.0M | 0.00% |
PreviousPage 2 of 2